<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, Transforming Growth Factor beta (TGFbeta) increases proliferation and promotes invasion via selective loss of signalling pathways </plain></SENT>
<SENT sid="1" pm="."><plain>Oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> arises from <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, progresses rapidly and is usually fatal </plain></SENT>
<SENT sid="2" pm="."><plain>The contribution of perturbed TGFbeta signalling in the promotion of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in this disease has not been elucidated </plain></SENT>
<SENT sid="3" pm="."><plain>We therefore investigated the role of TGFbeta in Barrett's associated oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> using a panel of cell lines (OE33, TE7, SEG, BIC, FLO) </plain></SENT>
<SENT sid="4" pm="."><plain>4/5 <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cell lines failed to cell cycle arrest, down-regulate c-Myc or induce p21 in response to TGFbeta, and modulation of a Smad3/4 specific promoter was inhibited </plain></SENT>
<SENT sid="5" pm="."><plain>These hyperproliferative <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cell lines displayed a TGFbeta induced increase in the expression of the extracellular matrix degrading proteinases, urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor 1 (PAI-1), which correlated with an invasive <z:mp ids='MP_0005384'>cell phenotype</z:mp> as measured by in vitro migration, invasion and cell scattering assays </plain></SENT>
<SENT sid="6" pm="."><plain>Inhibiting ERK and JNK pathways significantly reduced PAI and uPA induction and inhibited the invasive <z:mp ids='MP_0005384'>cell phenotype</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that TGFbeta Smad-dependent signalling is perturbed in Barrett's <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>, resulting in failure of <z:mpath ids='MPATH_73'>growth-arrest</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>However, TGFbeta can promote PAI and uPA expression and invasion through MAPK pathways </plain></SENT>
<SENT sid="9" pm="."><plain>These data would support a dual role for TGFbeta in oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>